Aidoc
Aidoc is one of the leading AI-enabled diagnostics providers globally, with a broad platform focused on radiology AI, emergency detection, imaging workflow triage, and clinical coordination. The company’s tools are designed to analyze medical imaging studies and identify suspected acute findings that may require rapid physician attention.
- Highest 2026 tier: Tier I
- AI-Enabled Diagnostics Providers
- 1 ranking category
Overview
Aidoc is one of the leading AI-enabled diagnostics providers globally, with a broad platform focused on radiology AI, emergency detection, imaging workflow triage, and clinical coordination. The company’s tools are designed to analyze medical imaging studies and identify suspected acute findings that may require rapid physician attention.
Aidoc’s strength lies in its breadth of FDA-cleared imaging algorithms and its platform-oriented deployment model. Rather than offering only a single narrow diagnostic tool, Aidoc supports multiple clinical findings across CT and X-ray workflows, including emergency and high-acuity use cases. Axios reported in 2026 that Aidoc had 31 FDA clearances and had raised $150 million in Series E funding led by Goldman Sachs Alternatives, with participation from major strategic investors.
Aidoc is included in 1 2026 ranking category. Its highest classification is Tier I. Ranking recognition is category-specific editorial evidence rather than a substitute for independent diligence.
Firm facts
| Public identity | Aidoc |
| Founded | 2016 |
| Institution type | AI-Enabled Diagnostics Providers institution |
| Headquarters | Tel Aviv / New York |
| Primary focus | AI-Enabled Diagnostics Providers |
| Highest 2026 ranking tier | Tier I |
Principal activities
Aidoc’s strength lies in its breadth of FDA-cleared imaging algorithms and its platform-oriented deployment model. Rather than offering only a single narrow diagnostic tool, Aidoc supports multiple clinical findings across CT and X-ray workflows, including emergency and high-acuity use cases. Axios reported in 2026 that Aidoc had 31 FDA clearances and had raised $150 million in Series E funding led by Goldman Sachs Alternatives, with participation from major strategic investors.
Core capability
AI-Enabled Diagnostics Providers
Client relevance
Category-specific capability, institutional credibility and the ability to support demanding professional, commercial or patient needs.
Execution and verification
Current service scope, leadership, geographic coverage, legal entities and regulated activities should be confirmed directly.
Sector and mandate coverage
Primary category
AI-Enabled Diagnostics Providers
Institutional context
Coverage reflects the institution’s role in the ranking categories listed below. Precise services, products, jurisdictions, clinical scope and client eligibility should be verified for each use case.
Market position
Aidoc’s regulatory footprint, hospital adoption, platform breadth, and focus on real-world clinical workflow support its position as a leading AI-enabled diagnostics provider in 2026.
Aidoc is assessed through public institutional information and Ranking News editorial research. Its strongest 2026 result is Tier I.
Competitive context
The relevant peer set varies by category, geography, client segment and mandate. Aidoc should be compared on current category-specific capability, senior involvement, evidence of comparable work, operating resilience and any applicable regulatory or clinical permissions.
Comparable institutions are shown for navigation and market context. Inclusion does not imply identical scale, ownership, geographic coverage, service model or regulatory status.
Leadership and governance
Leadership, ownership, governance and senior-team responsibilities may change. Current information should be verified through authoritative institutional sources.
Corporate and public information
The public-facing organization is identified here as Aidoc. Contracting entities, regulated affiliates, clinical operations, offices and legal permissions may differ by service and jurisdiction.
Corporate and disclosure information
| Organization | Aidoc |
| Headquarters | Tel Aviv / New York |
| Verification note | Confirm legal entity, licenses, offices and engagement terms directly before appointment or use. |
Rankings and recognition
Ranking inclusion and tier classification are editorial determinations. They should be read as category-specific assessments rather than universal league-table positions. The existence or maintenance of this Wiki profile does not influence ranking eligibility, tier or position.
Related Economy analysis
Selected reporting and market analysis from The Economy provides context for the institution’s operating environment:
- Healthcare Rankings and the New Economics of Expertise
- Healthcare Market Structure Is Opening a New Lane for Specialist Providers
- Healthcare Rankings and the New Geography of Distributed Care
Related institutions and subjects
Sources and data transparency
Official institutional information, where available, is used for current public identity and capabilities. Ranking pages document 2026 category and tier status. Economy articles provide market context rather than institution-specific endorsement.
- Healthcare Ranking — Top 30 AI-Enabled Diagnostics Providers 2026 — 2026 inclusion and tier classification.
- The Economy — Healthcare Rankings and the New Economics of Expertise — market context.
- The Economy — Healthcare Market Structure Is Opening a New Lane for Specialist Providers — market context.
- The Economy — Healthcare Rankings and the New Geography of Distributed Care — market context.
